(Q40721903)

23 September 2017

1 reference

title

The treatment of human African trypanosomiasis (English)

1 reference

23 September 2017

0 references

African trypanosomiasis

0 references

author name string

Pépin J

series ordinal

1

1 reference

PubMed ID

8122565

23 September 2017

Milord F

series ordinal

2

1 reference

23 September 2017

1 January 1994

1 reference

23 September 2017

Advances in Parasitology

1 reference

23 September 2017

33

1 reference

23 September 2017

1-47

1 reference

Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Pharmacokinetics of diminazene in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The treatment of advanced cases of Rhodesian sleeping sickness by Mel. B. and arsobal

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Four years' experience of melarsen oxide/BAL in the treatment of late-stage Rhodesian sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Nitrofurazone in the treatment of sleeping sickness due to Trypanosoma rhodesiense

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Polyamine metabolism: a potential therapeutic target in trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Necessity of antibody response in the treatment of African trypanosomiasis with alpha-difluoromethylornithine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Parasitic infections in women and their consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Present status of chemotheraphy and chemoprophylaxis of human trypanosomiasis in the Western Hemisphere

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-l-methionine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Use of a specific and sensitive assay to determine pentamidine pharmacokinetics in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Pentamidine transport in Trypanosoma brucei—Kinetics and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The efficacy of certain trypanocidal compounds against Trypanosoma gambiense infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Nitrofurazone therapy of Trypanosoma gambiense sleeping sickness in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Trypanothione metabolism and rational approaches to drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Trypanosoma brucei: Suramin and other trypanocidal compounds' effects on sn-glycerol-3-phosphate oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Further studies on the mode of action of arsenicals on trypanosome pyruvate kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Mel B in the treatment of human trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Flow cytofluorimetric analysis of drug accumulation by multidrug-resistant Trypanosoma brucei brucei and T. b. rhodesiense

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The chemoprophylaxis of sleeping sickness with the diamidines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Existing chemotherapy and its limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Kinetics of alpha-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Late results of treatment of sleeping sickness in Sierra Leone by antrypol tryparsamide pentamidine and propamidine singly and in various combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Estimation of the concentration of melarsoprol (Mel B) and Mel W in biological fluids by bioassay with trypanosomes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

1 reference

7 January 2021

Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Berenil in the treatment of Trypanosoma gambiense infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Chemotherapy of trypanosomiasis: the potentiation of melarsoprol by concurrent difluoromethylornithine (DFMO) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Pharmacokinetic investigations on diminazene and rolitetracycline in comparison to a combination of both

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Suramin-induced polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Toxicity of beril in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Treatment of Sleeping Sickness in Sierra Leone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Trypanosoma brucei: detection of low parasitaemias in mice by a miniature anion-exchanger/centrifugation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Antagonism by polyamines of the curative effects of alpha-difluoromethylornithine in Trypanosoma brucei brucei infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Eflornithine Treatment of Refractory Pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Polyamine metabolism and function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

1 reference

7 January 2021

The therapeutic effect on a group of sleeping sickness patients of a single injection of 3854 R.P. (mel B Friedheim-arsobal Spécia)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Suramin/metronidazole combination for African sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The trypanocidal effect of drugs in different parts of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

A TRIAL OF MEL W IN THE TREATMENT OF TRYPANOSOMA RHODESIENSE SLEEPING SICKNESS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Neurologic Complications Following the Treatment of Human Babesia Microti Infection with Diminazene Aceturate *

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Eflornithine for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a preliminary review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Second Report on the Treatment of Trypanosomiasis by Pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Investigations on mutagenicity and genotoxicity of pentamidine and some related trypanocidal diamidines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Pentamidine: Clinical pharmacologic correlations in man and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Treatment of Rhodesian sleeping sickness in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

The febrile response to treatment in Gambian sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

IgM and Antibody Measurement in the Diagnosis and Management of Gambian Trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2808%2960410-8

7 January 2021

10.1016/S0065-308X(08)60410-8

Identifiers

DOI

0 references

PubMed ID

8122565

1 reference

PubMed ID

8122565